TIDES Europe: Oligonucleotide and Peptide Therapeutics is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Informa

Dennis Åsberg
Research Scientist, Analysis & Separation at Novo Nordisk A/S

Profile

Dennis Åsberg is working as a Research Scientist in Global Research Technologies, at Novo Nordisk. He is developing analysis methods in the drug discovery phase for peptide and protein therapeutics and is coordinating transfer of analytical methods to CMC. He received his PhD from Karlstad University, Sweden, working with the analysis of small molecules in collaboration with AstraZeneca R&D, Gothenburg. The focus was on the incorporation of Quality by Design in regulated area to enable continuous improvements and life-cycle management of analytical methods.

Dennis Åsberg's Network

Agenda Sessions

  • Chairperson's Remarks

    , 13:40
  • Chairperson's Remarks

    , 13:40
  • Designing a Peptide Quantification Strategy for Early Drug Discovery – Ultraviolet, Refractive Index and Charged Aerosol Detection vs. Amino Acid Analysis

    , 14:45
  • Designing a Peptide Quantification Strategy for Early Drug Discovery – Ultraviolet, Refractive Index and Charged Aerosol Detection vs. Amino Acid Analysis

    , 14:45